Published in Am J Respir Cell Mol Biol on April 01, 1990
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology (1991) 1.55
Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung. Thorax (1996) 0.97
In vitro modulation of the eosinophil-dependent enhancement of the permeability of the bronchial mucosa. Br J Pharmacol (1991) 0.96
Effect of platelet activating factor on formation and composition of airway fluid in the guinea-pig trachea. J Physiol (1990) 0.82
The role of eosinophils in asthma. Lung (1990) 0.79
Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor. Immunology (2000) 0.79
Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics. Immunology (1993) 0.79
The orl rat is more responsive to methacholine challenge than wild type. Pulm Pharmacol Ther (2014) 0.76
Constitutive production of granulocyte/macrophage colony-stimulating factor by hypodense mononuclear eosinophils developed in vitro from hybrid eosinophil/basophil granulocytes. Proc Natl Acad Sci U S A (1996) 0.75
Medical and dental staffing prospects in the NHS in England and Wales 1993. Health Trends (1994) 13.22
Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 9.08
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Generation and analysis of 280,000 human expressed sequence tags. Genome Res (1996) 8.27
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology (2001) 6.55
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (1996) 5.53
Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med (2001) 5.47
New approach to primary medical care. Nine-point plan for a family practice service. Can Fam Physician (1994) 5.42
Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
The C. elegans genome sequencing project: a beginning. Nature (1992) 5.36
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24
BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax (2009) 5.23
Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) (1998) 4.31
Failed intubation revisited: 17-yr experience in a teaching maternity unit. Br J Anaesth (1996) 4.18
Rural background and clinical rural rotations during medical training: effect on practice location. CMAJ (1999) 4.12
Fringe is a glycosyltransferase that modifies Notch. Nature (2000) 4.09
Non-invasive sampling of nasal cilia for measurement of beat frequency and study of ultrastructure. Lancet (1980) 3.73
Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet (2001) 3.48
Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med (1999) 3.44
Asthma as an axon reflex. Lancet (1986) 3.26
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet (1982) 3.21
Symptomatic valvular myxomatous transformation (the floppy valve syndrome). A possible forme fruste of the Marfan syndrome. Circulation (1965) 3.16
Exhaled markers of pulmonary disease. Am J Respir Crit Care Med (2001) 3.14
Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol (2000) 3.13
Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract (2001) 3.06
[German guideline for diagnosis and management of idiopathic pulmonary fibrosis]. Pneumologie (2013) 3.03
Neural control of human airways in health and disease. Am Rev Respir Dis (1986) 2.97
The diagnosis and management of chronic cough. Eur Respir J (2004) 2.96
Primary ciliary dyskinesia: diagnosis and standards of care. Eur Respir J (1998) 2.81
Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J (1997) 2.79
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med (1997) 2.77
Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax (1998) 2.71
A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest (2001) 2.66
Exacerbations of chronic obstructive pulmonary disease. Eur Respir J (2007) 2.65
Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis (1987) 2.64
Cytokines in asthma. Thorax (1999) 2.64
Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun (1988) 2.56
Inflammatory mediators of asthma: an update. Pharmacol Rev (1998) 2.54
Computer assisted management of warfarin treatment. Br Med J (Clin Res Ed) (1984) 2.54
Isolation and complementation of mutants of Anabaena sp. strain PCC 7120 unable to grow aerobically on dinitrogen. J Bacteriol (1988) 2.49
An encyclopedia of mouse genes. Nat Genet (1999) 2.48
Fringe modulates Notch-ligand interactions. Nature (1997) 2.44
Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet (1986) 2.41
Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest (1987) 2.40
zA map for sequence analysis of the Arabidopsis thaliana genome. Nat Genet (1999) 2.39
ERS guidelines on the assessment of cough. Eur Respir J (2007) 2.36
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax (2010) 2.36
Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough. Thorax (2004) 2.36
Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res (1997) 2.34
Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol (1998) 2.33
The measurement of opsonic and phagocytic function by Luminol-dependent chemiluminescence. Immunology (1980) 2.33
Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med (2000) 2.33
Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med (1996) 2.32
Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med (1992) 2.32
Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ Res (2000) 2.29
Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med (1995) 2.28
Difficult asthma. BMJ (1989) 2.28
Volunteering for early phase gene transfer research in Parkinson disease. Neurology (2006) 2.27
Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer. Lancet (1990) 2.25
A simple oral antimicrobial regimen effective in severe chronic bronchial suppuration associated with culturable Haemophilus influenzae. J Antimicrob Chemother (1983) 2.25
Effects of hospitalists on cost, outcomes, and patient satisfaction in a rural health system. Am J Med (2000) 2.23
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Exhaled carbon monoxide in childhood asthma. J Pediatr (1999) 2.19
Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med (1998) 2.19
Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J (2001) 2.18
Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J (2004) 2.18
Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17
A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci (1989) 2.17
Inflammatory mediators and asthma. Pharmacol Rev (1988) 2.17
Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal. Clin Infect Dis (2000) 2.14
Association mapping of disease loci, by use of a pooled DNA genomic screen. Am J Hum Genet (1997) 2.07
Fourier transform infrared microspectroscopy is a new way to look at plant cell walls. Plant Physiol (1992) 2.07
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J (2004) 2.06
Direct inguinal herniation in men: a disease of collagen. J Surg Res (1974) 2.06
Rearrangement of immunoglobulin genes. Biochemistry (1979) 2.04
Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J (2002) 2.04
[Therapeutic approaches to acute pulmonary embolism]. Internist (Berl) (2004) 2.03
Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med (2000) 2.03
Readers advocate pro-conscience, not pro-choice. Nurse Pract (1992) 2.01
Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med (1997) 2.01
The effect of airway epithelium on smooth muscle contractility in bovine trachea. Br J Pharmacol (1985) 1.98
Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun (2004) 1.98
Mercury exposure and risks from dental amalgam in the US population, post-2000. Sci Total Environ (2011) 1.97
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96
Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun (1994) 1.96